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abdominal aortic repair: A comparison with patients without prior
treatment
Gioacchino Coppi, Stefano Gennai, Giuseppe Saitta, Roberto Silingardi,
Sebastiano Tasselli
Objective: A retrospective analysis of immediate outcomes following aneu-
rysm rupture (rAAA) in two groups: patients previously treated at our center
with primary endovascular repair (EVAR) and patients without previous EVAR
for abdominal aortic aneurysms (AAA) in an 8-year period.
Methods: Fourteen patients with a confirmed rAAA identified throughout
the follow-up period following primary EVAR repair at our center (from a po-
pulation of 820 AAA treated at our center in election) were retrospectively
compared with 155 patients without previous EVAR in the same time period,
from the introduction of an intention-to-treat protocol with EVAR for rAAA in
January 1999. Primary study outcomes included 30-day mortality and severe
systemic complications following rAAA correction with both open and EVAR
treatments.
Results: In the 14 patients secondary interventions were necessary
throughout follow-up prior to rupture in 43% (6/14). The mean time to
rupture was 50.23 months (9-113). The mean increase in maximum aneu-
rysmal diameter at rupture was 18.39 mm. Type of endoleaks observed at
rupture: 35.7% I proximal, 35.7% III contralateral stump disconnection,
14.3% I distal, 14.3% III midgraft tear: treatment at rupture included five
EVAR corrections with aortouniiliac endografts, four EVAR corrections with
extensions, and five surgical conversions. Thirty-day mortality between
the two groups, 28.5% (patients with prior EVAR) 38.7% (patients without
prior EVAR), and severe systemic complications, 50% vs 37.6%, were not
found to be statistically significant. Hemodynamic instability, 36% (patients
with prior EVAR) 63% (patients without prior EVAR), was found to be an inde-
pendent predictor of 30-day mortality (P < .0001), whereas severe systemic
complications, 50% vs 33.5%, did not influence the same outcome (P = .852).
Conclusions: In terms of mortality, it would be logical to expect a protection
from the endograft in patients with previous EVAR. A trend seems to confirm
this assumption, but no statistical significance was found, which may be due
to the small population size.Intracranial hemorrhage after carotid endarterectomy and carotid
stenting in the United States in 2005
Carlos H. Timaran, Frank J. Veith, Eric B. Rosero, J. Gregory Modrall, R.
James Valentine, G. Patrick Clagett
Background: Intracranial hemorrhage (ICH) following carotid endarterec-
tomy (CEA) or carotid artery stenting (CAS) is a rare but potentially devas-
tating complication. The effect of more intense dual antiplatelet therapy
required for CAS on the frequency of ICH has not been established. This
study was undertaken to evaluate the nationwide occurrence of ICH associ-
ated with CAS vs CEA.
Methods: The Nationwide Inpatient Sample was used to identify patients
discharged after CAS and CEA during 2005. The type of revascularization
and major adverse events, ie, in-hospital ICH, postprocedural stroke, and
death rates, were determined by cross-tabulating specific procedural codes* Full articles available online at www.jvascsurg.org
1078e5884/$34.00
doi:10.1016/S1078-5884(09)00022-7for CAS and CEA and diagnostic codes for carotid stenosis. Risk stratification
was performed using the Charlson Comorbidity Index. Univariate and multi-
variate logistic regression analyses were used to assess the association
between type of revascularization, comorbidities, ICH, and risk-adjusted
mortality.
Results: In 2005, the estimated number of carotid revascularizations was
135,903. The vast majority of patients underwent CEA (90.4%), whereas
CAS was performed in 13,093 (9.6%) patients. Most patients (92.2%) under-
went treatment for asymptomatic carotid stenosis. CAS patients had higher
postoperative stroke rates (2.1% vs 1.1%; P < .001) and in-hospital mortality
(1.1% vs 0.6%; P < .001) than CEA patients. ICH occurred in 19 patients
(0.15%) after CAS and in 20 patients (0.016%) after CEA (P < .001). CAS
was identified as an independent predictor for postoperative stroke (odds
ratio [OR], 1.77; 95% confidence interval [CI], 1.5-2.0; P < .001), in-hospital
mortality (OR, 1.49; 95% CI, 1.2-1.8; P < .001) and ICH (OR, 5.9; 95% CI, 3.1-
11.1; P < .001) after adjusting for age, gender, symptomatic status, comor-
bidities, admission, and hospital type using logistic regression. In-hospital
mortality was 12.5% among patients developing ICH (OR, 23.2; 95% CI, 9.1-
54.4; P < .001).
Conclusion: In the United States, patients undergoing CAS have not only
significantly increased postoperative stroke and death rates compared with
those undergoing CEA, but also a sixfold increased risk of ICH. Although ICH
after CAS is extremely rare, its devastating nature and high mortality
warrant further investigation to define specific risk factors, prevention,
and treatment strategies.Surgical intervention for thoracic outlet syndrome improves patient’s
quality of life
David C. Chang, Lisa A. Rotellini-Coltvet, Debraj Mukherjee, Ricardo De
Leon, Julie A. Freischlag
Objective: To assess long-term quality of life outcomes in patients following
transaxillary first-rib resection and scalenectomy for thoracic outlet
syndrome (TOS).
Methods: This was a prospective observational study using the Short-Form
12 (SF-12) and Disability of Arm, Hand, and Shoulder (DASH) instruments
between February 2005 and March 2008 in patients with TOS presenting to
an academic medical center for preoperative surgical evaluation after
failing physical therapy protocol. Surveys were conducted preoperatively
and then again at 3, 6, 12, 18, and 24 months after surgery. Longitudinal
data analysis was performed with population-averaged models using
generalized estimating equations (GEE) method for average rate of recovery.
Kaplan-Meier method was used to analyze time to return to work.
Results: A total of 70 out of 105 eligible patients (66.7%) completed the
study protocol (44 neurogenic; 26 venous), returning 243 valid SF-12 surveys
(162 neurogenic; 81 venous) and 188 valid DASH surveys (124 neurogenic; 64
venous). Half (50%) of the neurogenic patients and 77% of the venous
patients returned to full-time work or activity within the study follow-up,
with half of them doing so by 4 months and 75% of them by 5 months. There
was no statistically significant difference in return to work between the
neurogenic or venous patients. Neurogenic patients had baseline SF-12 Phys-
ical Component Scores (PCS) similar to chronic heart failure patients and
were significantly worse than venous patients (33.8 vs 43.6, P < .001). In
contrast, no difference existed in Mental Component Scores (MCS) (44.5 vs
43.5, P = .78). In follow-up, on average, PCS scores for neurogenic patients
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month (P = .01); while PCS scores for venous patients improved 0.40 points
(P = .004) and MCS scores improved 0.55 points per month (P < .001). Addi-
tionally, neurogenic patients had baseline DASH scores that were similar to
patients with rotator cuff tears, and they were also significantly worse than
venous patients (50.2 vs 25.0, P < .001). DASH scores, on average, also
improved 0.85 points (P < .001) for neurogenic patients and 0.81 points (P
< .001) for venous patients per month.
Conclusion: The use of the SF-12 and DASH instruments in patients with TOS
demonstrated significant improvement in patients postoperatively. Venous
TOS patients typically improved both physical and mental scores in shorter
periods of time than their neurogenic counterparts. Neurogenic and venous
TOS patients returned to full-time work/activity within the same length of
time postoperatively. However, neurogenic patients required more
secondary interventions. We conclude that in appropriately selected
patients with either neurogenic or venous TOS, surgical intervention can
improve their quality of life over time.
Clinical Relevance: Surgical intervention is associated with significant
improvement in quality of life for TOS patients. Venous TOS patients
improved physical and mental function in shorter time than neurogenic
counterparts. The majority of patients were able to return to full-time work
or activity by 6 months, while they continued to recover their quality of life.
There was no difference in time to return to work or activity between neuro-
genic and venous patients; however, neurogenic patients required more
secondary interventions. In appropriately selected patients with either
neurogenic or venous TOS, surgical intervention can improve their quality
of life over time.Improved outcomes are associated with multilevel endovascular
intervention involving the tibial vessels compared with isolated tibial
intervention
Mikel Sadek, Sharif H. Ellozy, Irene C. Turnbull, Robert A. Lookstein, Michael
L. Marin, Peter L. Faries
Objective: Endovascular intervention is increasingly accepted as an alterna-
tive to surgery for the treatment of tibial vessel disease. Tibial vessel
disease can occur in isolation or in conjunction with disease that involves
the proximal lower extremity vasculature (multilevel disease). This study
evaluated the overall efficacy of endovascular intervention for tibial vessel
disease and whether the requirement for single-level compared with multi-
level intervention affected outcomes.
Methods: This study evaluated a consecutive unselected group of patients
who underwent an infrapopliteal intervention from November 2002 to
February 2008. The primary end points evaluated were technical success,
limb salvage, primary patency, and secondary patency. The secondary end
points evaluated were 30-day access site (ie, hematoma, pseudoaneurysm,
and wound infection), intervention site (ie, thrombosis), and systemic (ie,
acute renal failure, myocardial infarction, and mortality) complications.
Patency and limb salvage were evaluated using Kaplan-Meier life-table anal-
yses and compared using Cox regression analysis. P < .05 was considered
statistically significant.
Results: The study comprised 85 patients, 89 limbs, and 114 procedures.
Age was 72.4  13.1 years, 67% were men, and follow-up was 245.8 
290.8 days. The technical success rate for all procedures was 91%. Limb
salvage rates for patients with critical limb ischemia at 6, 12 and 18 months
were 85%  0%, 81%  0%, and 69%  0%, respectively. For the complete
patient cohort, primary patency rates at 6, 12 and 18 months were 68% 
6%, 50%  8%, and 37%  9%, respectively, and secondary patency rates were
81%  5%, 71%  7%, and 63%  8%. Multilevel intervention was associated
with significantly improved secondary patency compared with single-level
intervention (P = .045).
Conclusions: Patency and limb salvage rates for endovascular treatment of
tibial vessel disease in this study are comparable with prior reports and
with historical surgical controls. Patients who undergo multilevel interven-
tion involving the tibial vessels exhibit improved secondary patency
compared with those who undergo intervention for lesions isolated to the
tibial vessels. This may reflect increased distal disease burden for patients
who undergo isolated tibial intervention. The study data suggest that the
presence of multilevel disease should not preclude an attempt at percuta-
neous revascularization. Further study is required before formulating defin-
itive recommendations for the endovascular treatment of tibial vessel
disease.Operative vs interventional treatment for ostial renal artery occlusive
disease (RAOOD): Results of a prospective randomized trial
Kai M. Balzer, Tomas Pfeiffer, Sebastian Rossbach, Adina Voiculescu, Ulrich
Mo¨dder, Erhard Godehardt, Wilhelm Sandmann
Introduction and Objectives: Patients with either renovascular hyperten-
sion (RVH) and/or renal insufficiency (RI) due to renal artery ostial occlusive
disease (RAOOD) can successfully undergo an open surgical reconstruction
procedure (OSRP), but since the publication of Blum et al percutaneous
balloon stent angioplasty (PTRA + stent) leaving a small part of the stent
within the aorta has become very popular. However, balloon dilatation
and stenting does not remove the atherosclerotic plaque, which is often
heavily calcified but leads to disruption of the plaque causing myointimal
hyperplasia and recurrent stenosis. Therefore, a comparison of the two
treatment modalities concerning complications and durability in a prospec-
tive randomized design was felt to bring more insight to the discussion.
Methods: From 1998 to 2004, we performed OSRP in 330 patients with RVH
and/or RI for various locations of RAOOD. During this time period, 50
patients (female 18, male 32, mean age 64.4 years) with RAOOD of at least
70% stenosis (DSA and duplex criteria) in one or both renal arteries, who did
not require other aorto/mesenteric/iliac reconstructive procedures agreed
and were randomized to either OSRP (n = 25 patients, 49 arteries) or PTRA
+ stent (n = 25 patients, 28 arteries). Two patients crossed over to surgical
treatment. Patients were followed on a regular basis for 4 years and longer.
Endpoints were re-occurrence of RAOOD and impairment of either kidney
function or RVH.
Results: We approached 77 arteries. There was no early mortality in either
group, but directly procedure-related morbidity was 13% in the interven-
tional group and 4% in the surgical group. Four-year follow-up mortality
was 18% in the interventional group and 25% in the surgical group. Both
groups showed significant improvement of RVH (P < .001 in each group) as
well as improvement or stabilization in patients with insufficient renal func-
tion. Freedom from recurrent RAOOD (>70%) was achieved in 90.1% of the
surgical group and 79.9% of the interventional group.
Conclusion: Both treatment modalities showed good early results concern-
ing RVH, kidney function, and renal perfusion. Despite a higher number of
bilateral renal artery reconstructions in patients undergoing OSRP, which
was probably due to the preferred technique of transaortic endarterectomy
eliminating the plaque originating in the aorta and usually extending into
both renal arteries, mortality was not higher and procedure-related
morbidity was even lower compared to PTRA + stent. These findings and also
longer durability of OSRP imply that surgical reconstruction remains the gold
standard for patients with RAOOD before PTRA + stent may be considered.Outcome after endovascular stent graft repair of aorto-enteric fistula: A
systematic review
George A. Antoniou, Stylianos Koutsias, Stavros A. Antoniou, Andreas
Georgiakakis, Miltos K. Lazarides, Athanasios D. Giannoukas
Background: Aorto-enteric fistula (AEF) is a critical clinical condition, which
may present with gastrointestinal hemorrhage, with or without signs of
sepsis. Conventional open surgical repair is associated with high morbidity
and mortality. Endovascular stent graft repair has been attempted, but
recurrent infection remains of major concern. We conducted a systematic
review to assess potential factors associated with poor outcome after endo-
vascular treatment.
Methods: The English literature was searched using the MEDLINE electronic
database up to April 2008. All studies reporting on the primary management
of primary or secondary AEF with endovascular stent graft repair were
considered.
Results: Data were extracted from 33 reports that included 41 patients and
were entered in the final analysis. Persistent/recurrent/new infection or
recurrent hemorrhage developed in 44% of the patients, after a mean
follow-up period of 13 months (range, 0.13-36). Secondary, as compared
to primary, AEF had an almost threefold increased risk of persistent/recur-
rent infection. Evidence of sepsis preoperatively was found to be a factor
indicating unfavorable outcome (P < .05). Persistent/recurrent/new infec-
tion after treatment was associated with worse 30-day and overall survival
compared with those who did not develop sepsis (P < .05).
Conclusion: Endovascular stent graft repair of AEF was associated with
a high incidence of infection or recurrent bleeding postoperatively. Evidence
of sepsis preoperatively was indicating poor outcome.
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W. Anthony Lee
Failure modes of thoracic endografts can be broadly categorized as those
that typically occur early in the perioperative period and those that occur
during late follow-up. In the former category, failures principally involve
delivery, deployment, and conformation to the local anatomy. In the
postoperative period, failures can manifest as endograft collapse, compo-
nent separations, and metallic fractures and fabric tears. Some of these
events are preventable with careful case selection, planning, and
procedural technique, but others require active management with
advanced endovascular or surgical adjuncts. No endograft system is
immune from these problems. Endograft failure is an equal-opportunity
hazard, which underscores the absolute need for diligent, long-term
follow-up.Early outcomes after endovascular management of acute, complicated
type B aortic dissection
Robert J. Feezor, Tomas D. Martin, Philip J. Hess Jr, Thomas M. Beaver,
Charles T. Klodell, W. Anthony Lee
Objectives: Surgical management of acute, complicated type B aortic
dissection is associated with significant morbidity and mortality. This study
examined the feasibility and safety of endovascular treatment of this
pathology.Methods: We reviewed a prospectively maintained thoracic endovascular
database and medical records at a single institution from 2005 to 2007.
The study group comprised acute, complicated type B dissections, defined
as duration of symptoms 14 days involving false lumen rupture, malperfu-
sion, intractable pain, or hypertension. All repairs were performed using the
TAG device (W. L. Gore and Associates, Flagstaff, Ariz). Select 30-day or in-
hospital outcomes were reported.
Results: Of the 216 thoracic endovascular aortic aneurysm repairs per-
formed during the study period, 33 (15%) were for acute, complicated type
B dissections. There were eight women (24%). The mean age was 61  15
years. The average duration of symptoms was 2.9  4.1 (median, 1) days.
The indications for repair included rupture in 15 patients (46%) and mesen-
teric/renal/lower extremity malperfusion in 11 (33%). Mean fluoroscopy
time and contrast volume were 30  16 minutes and 176  55 mL, respec-
tively. Eight (73%) of 11 patients with malperfusion required branch vessel
stenting. The 30-day in-hospital mortality was 21% (7 of 33). Causes of death
included cardiac arrest in 3, progressive multisystem organ failure in 2,
rupture in 1 and unknown in 1. At least one major complication occurred
in 76% of the patients, including respiratory failure in 11 (33%), permanent
spinal cord ischemia in 5 (15%), renal failure requiring dialysis in 4 (12%),
and stroke in 4 (12%). The mean postoperative length of stay was 17.2 
16.5 days, and only 14 (42%) were discharged to home.
Conclusions: Emergency endovascular repair of acute, complicated type B
dissection is associated with significant mortality and morbidity. The overall
role of this therapy in the treatment of this lethal problem should be better
defined and compared with other surgical or interventional options before
being generally adopted.
